疾病预防试验中纵向离散结局的多状态模型分析:功效与样本量
针对参与者经历多个离散健康状态并产生纵向测量的临床试验,本文通过分析一项III期压力性溃疡预防策略试验的数据,阐明可能考虑的估计目标,并通过模拟研究显示在某些情况下使用多状态模型分析可将样本量减半而不影响试验功效。
要点
- 多状态模型可作为疾病预防试验的主要分析方法。
- 模拟研究显示某些情况下样本量可减半且不损害功效。
- 评估时间安排等设计特征可能受多状态模型影响。
核心结论
- 在某些情况下,基于多状态模型的分析可将样本量减半而不影响试验功效。
研究设计与样本
- 通过分析一项III期压力性溃疡预防策略试验的数据进行方法展示,并开展模拟研究。
主要发现
- 模拟研究表明,在某些情况下使用多状态模型分析可使样本量减少一半,且不损害试验功效。
临床怎么用
- 在疾病预防试验中可考虑将多状态模型作为主要分析方法以潜在减少样本量。
局限性
- 关于多状态模型作为主要分析方法及其对设计特征(如评估时间安排)影响的已发表文献很少。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
For clinical trials where participants pass through a number of discrete health states resulting in longitudinal measures over time, there are several potential primary estimands for the treatment effect. Incidence or time to a particular health state are commonly used outcomes but the choice of health state may not be obvious and these estimands do not make full use of the longitudinal assessments. Multistate models have been developed for some diseases and conditions with the purpose of understanding their natural history and have been used for secondary analysis to understand mechanisms of action of treatments. There is little published on the use of multistate models as the primary analysis method and potential implications on design features, such as assessment schedules. We illustrate methods via analysis of data from a motivating example; a Phase III clinical trial of pressure ulcer prevention strategies. We clarify some of the possible estimands that might be considered and we show, via a simulation study, that under some circumstances the sample size could be reduced by half using a multistate model based analysis, without adversely affecting the power of the trial.
引用
- Smith IL, Nixon JE, Sharples L, et al. Power and sample size for multistate model analysis of longitudinal discrete outcomes in disease prevention trials. Stat Med. 2021. PMID: 33550652. doi:10.1002/sim.8882
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。